(Q47419398)

16 January 2018

title

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy (English)

1 reference

16 January 2018

relapsing-remitting multiple sclerosis

main subject

Italy

0 references

multiple sclerosis

0 references

0 references

author

Paolo Livrea

9

1 reference

16 January 2018

Maria Liguori

object named as

Maria Liguori

2

0 references

Maria Trojano

object named as

Maria Trojano

1

0 references

author name string

Damiano Paolicelli

3

1 reference

16 January 2018

Giovanni Bosco Zimatore

4

1 reference

16 January 2018

Francesca De Robertis

5

1 reference

16 January 2018

Carlo Avolio

6

1 reference

16 January 2018

Fabrizio Giuliani

7

1 reference

16 January 2018

Aurora Fuiani

8

1 reference

16 January 2018

Southern Italy MS Group

10

1 reference

16 January 2018

publication date

1 October 2003

1 reference

16 January 2018

Multiple Sclerosis Journal

published in

1 reference

16 January 2018

volume

9

1 reference

16 January 2018

issue

5

1 reference

16 January 2018

page(s)

451-457

1 reference

16 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS948OA

10.1191/1352458503MS948OA

21 January 2018

Identifiers

DOI

1 reference

16 January 2018

PubMed ID

14582768

1 reference

16 January 2018